M MELTECH Trademark

Trademark Overview


On Monday, October 16, 2017, a trademark application was filed for M MELTECH with the United States Patent and Trademark Office. The USPTO has given the M MELTECH trademark a serial number of 87646531. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, January 31, 2025. This trademark is owned by Dexcel Pharma Technologies Ltd.. The M MELTECH trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations in the form of orally disintegrating tablets and orally disintegrating medicaments for the treatment of genetic, [ cardiovascular, ] central nervous system, endocrine, gastrointestinal, hepatic, biliary, immunological, allergic, pulmonary, [ dermatological, ] infectious, inflammatory, menopausal, nutritional, metabolic, diabetes, autoimmune, musculoskeletal, connective tissue, neurological, [ ophthalmologic, ] psychiatric, respiratory, [ urogenital, urological, erectile dysfunction, sexual dysfunction, ] gynecology, obstetric, [ pediatric, hematologic, oncological, ] fungal and viral diseases and disorders
m meltech

General Information


Serial Number87646531
Word MarkM MELTECH
Filing DateMonday, October 16, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, January 31, 2025
Registration Number5672365
Registration DateTuesday, February 12, 2019
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, November 27, 2018

Trademark Statements


Description of MarkThe mark consists of the word "MELTECH" appearing in stylized blue font with a stylized blue "M" appearing to the left of the wording and extending under the letters "MEL".
Goods and ServicesPharmaceutical preparations in the form of orally disintegrating tablets and orally disintegrating medicaments for the treatment of genetic, [ cardiovascular, ] central nervous system, endocrine, gastrointestinal, hepatic, biliary, immunological, allergic, pulmonary, [ dermatological, ] infectious, inflammatory, menopausal, nutritional, metabolic, diabetes, autoimmune, musculoskeletal, connective tissue, neurological, [ ophthalmologic, ] psychiatric, respiratory, [ urogenital, urological, erectile dysfunction, sexual dysfunction, ] gynecology, obstetric, [ pediatric, hematologic, oncological, ] fungal and viral diseases and disorders
Pseudo MarkMELT TECH MELT TECH
Indication of Colors claimedThe color(s) blue is/are claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 25, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDexcel Pharma Technologies Ltd.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressJerusalem 9123901
IL

Party NameDexcel Pharma Technologies Ltd.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
Address3060000 Or Akiva
IL

Party NameDexcel Pharma Technologies Ltd.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
Address3060000 Or Akiva
IL

Trademark Events


Event DateEvent Description
Wednesday, March 28, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 19, 2017NEW APPLICATION ENTERED
Wednesday, October 25, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 22, 2017ASSIGNED TO EXAMINER
Wednesday, December 27, 2017NON-FINAL ACTION WRITTEN
Wednesday, December 27, 2017NON-FINAL ACTION E-MAILED
Wednesday, December 27, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 14, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 14, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 15, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 18, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 30, 2018ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Friday, April 13, 2018PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, April 13, 2018LETTER OF SUSPENSION E-MAILED
Friday, April 13, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, April 13, 2018SUSPENSION LETTER WRITTEN
Friday, October 5, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, October 17, 2018ASSIGNED TO LIE
Wednesday, October 17, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 17, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 7, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 27, 2018PUBLISHED FOR OPPOSITION
Tuesday, November 27, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 12, 2019REGISTERED-PRINCIPAL REGISTER
Friday, September 13, 2024TEAS SECTION 8 & 15 RECEIVED
Monday, February 12, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, January 31, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, January 31, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, January 31, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED